Press Release
Total 9, 1/2 Page
| No. | Subject | Writer | Date of Preparation | Views |
|---|---|---|---|---|
| 9 |
[Journal of Clinical Medicine] COVID-19 Phase 2 Clinical Study Results
|
ImmuneMed | 2022-05-26 | 8789 |
| 8 |
[Heliyon] hzVSF inhibits hepatitis B virus infection by targeting viral cell entry
|
ImmuneMed | 2022-05-26 | 8385 |
| 7 |
[Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment
|
ImmuneMed | 2021-01-08 | 6366 |
| 6 |
COVID-19 Phase 2 Clinical Study Approval (Italy), December 18th, 2020
|
ImmuneMed | 2020-12-21 | 6143 |
| 5 |
Obtaining Approval Letter of Investigational New Drug (IND) for COVID-19 Phase 2 Study in Republic of Korea on 7th December, 2020
|
ImmuneMed | 2020-12-07 | 1294 |
| 4 |
COVID-19 Phase 2 Clinical Study Approval (Indonesia), December 1st, 2020
|
ImmuneMed | 2020-12-01 | 5716 |